trending Market Intelligence /marketintelligence/en/news-insights/trending/lbvbobkbnlpqsd_i1dvgvw2 content esgSubNav
In This List

UroGen Pharma appoints COO

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


UroGen Pharma appoints COO

UroGen Pharma Ltd. appointed Stephen Mullennix as COO.

Mullennix previously served as the CFO and senior vice president of operations for SolarReserve LLC, a power company.